| Spring 2003 CARES Foundation, Inc. | |
| |
| Back to Spring 2003 Index | |
|
Will Restricted Distribution of EMLA® Cream Affect You? Stephanie Fracassa, New York, NY
|
| Regular blood work is a necessary part of managing CAH. The pain and discomfort associated with venipuncture can be reduced with the use of a topical anesthetic cream. EMLA, manufactured by Astra Zeneca, is one such cream.
On November 15, 2002 Astra Zeneca ceased distribution of EMLA Cream to all Drug Wholesalers and direct buying Retail Pharmacies because it had failed to comply with regulations regarding Child-Resistant Closure (CRC) packaging. After January 31, 2003 EMLA could no longer be dispensed for use outside of the hospital, in-patient setting. As an alternative, ELA-Max (Lidocaine 4%) Topical Anesthetic Cream is available from Ferndale Laboratories, Inc. ELA-Max is Prilocaine-free for safe use in children and adults. It is non-toxic with minimal systemic absorption and less vasoconstrictive than EMLA. ELA-Max delivers safe, effective topical anesthesia in 30 minutes or less without the need for occlusive dressings. ELA-Max is available in a variety of sizes: *15-gram tube ELA-Max is available WITHOUT PRESCRIPTION in child-resistant packaging. Look for it at your local pharmacy or purchase online at: www.dermadoctor.com Ferndale Laboratories Inc. manufactures ELA-Max Cream. For more information, call Ferndale Laboratories toll-free 1-877-ELA-MAX4 (352-6294) or (888) 548-0900 or go to their website: www.ferndalelabs.com. On their website, there is a press release dated Oct. 11, 2002 that explains why EMLA is no longer available.
|
||||
| ||||
 | ||||
| © 2003 CARES Foundation, Inc. All rights reserved. Republication or redistribution of CARES content, including by framing or similar means, is prohibited without the prior written consent of CARES. | ||||